Previous 10 | Next 10 |
2023-05-18 15:17:20 ET Summary Pfizer investors continue their scramble for the exit, forcing PFE into a two-year low, as investors turned highly pessimistic on Pfizer. Investors are increasingly worried about Pfizer's ability to navigate life after COVID while facing the loss of ...
2023-05-17 02:56:26 ET Summary Key update: as we predicted, FDA approval for LUMRYZ, a unique once-at-bedtime narcolepsy treatment. Orphan Drug Exclusivity is granted until May 1, 2030, offering attractive patent protection. Launch expected in June 2023, with a fast sales ramp ant...
2023-05-17 00:15:00 ET Summary One of the most promising applications of AI in drug discovery is in the identification of new drug targets (AI can be used to discover new drugs). The ability to analyze large amounts of molecular and genomic data quickly and efficiently is somethin...
2023-05-17 00:00:00 ET Summary Markets are being shaped by disparate trends from falling energy prices to rising interest rates. During first-quarter earnings season, company reports indicated that these crosscurrents are intensifying business challenges—and making it harde...
2023-05-16 18:55:18 ET Summary HSCT-TMA BLA Resubmission: Omeros plans to resubmit a BLA for narsoplimab, potentially gaining approval by Q2 2024. IgAN Trial Progress: Top-line results for the phase 3 ARTEMIS trial on narsoplimab for IgAN are expected in Q3 2023. Solid Financi...
2023-05-16 16:26:55 ET Summary Acquisition: Sobi acquires CTI BioPharma for ~$1.7 billion, an 85% premium, aligning with Sobi's focus on hematology. Confidence: Main shareholder Investor AB's agreement to rights issue signifies deal confidence; no overlapping drugs between SOBI an...
2023-05-16 14:35:00 ET Summary Both the Consumer Price Index and Producer Price Index data for April confirmed that the strong but lumpy disinflationary trend continues. The US is now at a point where the Fed funds rate exceeds inflation. Historically that has signaled the end of ...
2023-05-15 14:35:00 ET Summary The financial sector hasn’t seen much degradation of its expected 2023 growth rate of +13%, even with the regional bank issues. Despite the headlines, negative EPS revisions for the energy sector have been far worse than for the financial sect...
2023-05-12 20:23:29 ET The S&P 500 ( SP500 ) on Friday slipped 0.29% for the week to close at 4,124.08 points, posting losses in three out of five sessions. Its accompanying SPDR S&P 500 Trust ETF ( NYSEARCA: SPY ) fell 0.25% for the week. The benchmark index...
2023-05-10 05:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
SPDR Select Sector Fund - Health Care Company Name:
XLV Stock Symbol:
NYSE Market:
2024-07-09 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-29 11:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-09 09:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...